Market Watch – Page 518 – Biotech Insider

All Posts in "Market Watch"

Nasdaq books longest streak of record closes since 1998 as Boeing CEO’s exit lifts Dow

Nasdaq logs nine consecutive record closes

by Editor — December 24, 2019 By Editor in Market Watch

Asian markets quiet after latest Wall Street records

Nikkei about flat; Hang Seng slips in holiday-shortened session

by Editor — December 24, 2019 By Editor in Market Watch

The stock market could surge another 20% if the head of Merrill Lynch’s wealth management is right

‘This is a generational bull market’, says Sieg

by Editor — December 23, 2019 By Editor in Market Watch

Bold stock-market calls for 2020: Begin with GE and Google

Build your investment strategy for 2020

by Editor — December 23, 2019 By Editor in Market Watch

S&P 500, Dow and Nasdaq close at record highs, notch fourth straight week of gains

S&P 500 up for 7 out of last 8 trading days

by Editor — December 23, 2019 By Editor in Market Watch

Tesla’s stock rally costing shorts $1.6 billion

‘The worst of times’ to short Tesla, but don’t call it a squeeze, S3 says

by Editor — December 23, 2019 By Editor in Market Watch

Gold prices settle higher, then seesaw as Fed stands pat on interest rates

Investors continue to eye trade developments ahead of tariff deadline

by Editor — December 12, 2019 By Editor in Market Watch

European stocks slip as investors wait for U.K. election and central bank meetings

Inditex and Credit Suisse among stocks on the move

by Editor — December 12, 2019 By Editor in Market Watch

UPS is at risk as shrinking delivery times and smaller packages disrupt business model

‘Biggest driver of profitability for the industry is drop density, which is significantly lower for residential deliveries than business,’ says BMO

by Editor — December 12, 2019 By Editor in Market Watch

Apple AirPods and Apple Watches could help drive a return to growth, analyst says

Bank of America and Evercore just became more upbeat about Apple’s prospects

by Editor — December 12, 2019 By Editor in Market Watch

Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Biotech Insider is a wholly-owned subsidiary of Market IQ Media Group, Inc.

While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.